3 Stocks Improving Performance Of The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 68 points (0.4%) at 17,048 as of Thursday, Aug. 21, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,747 issues advancing vs. 1,215 declining with 171 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.2%, Grifols ( GRFS), up 0.9%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.7% and WellPoint ( WLP), up 0.6%. On the negative front, top decliners within the industry include Cyberonics ( CYBX), down 6.5%, and ResMed ( RMD), down 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.59 (0.7%) to $82.48 on light volume. Thus far, 418,342 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $81.70-$82.63 after having opened the day at $81.78 as compared to the previous trading day's close of $81.89.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $31.0 billion and is part of the health care sector. Shares are up 9.0% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts who rate Stryker Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Baxter International ( BAX) is up $0.83 (1.1%) to $76.08 on average volume. Thus far, 1.0 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $75.67-$76.34 after having opened the day at $76.25 as compared to the previous trading day's close of $75.25.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $40.7 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.44 (0.5%) to $83.87 on light volume. Thus far, 1.3 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $83.59-$84.10 after having opened the day at $83.60 as compared to the previous trading day's close of $83.43.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $81.1 billion and is part of the health care sector. Shares are up 10.8% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts who rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, revenue growth, reasonable valuation levels, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?